2 Under-the-Radar Stocks to Buy Now
COVID-19 testing company Lucira Health became public only in February, but it has been plagued by problems since. Lucira's flagship device is a single-use, do-it-yourself COVID-19 test kit that received regulatory clearance for over-the-counter use in April. Overall, it was a major innovation by Lucira Health, but it came a tad bit too late.